Please read this PDF publication : 15 years for Diex Research
Happy Holidays from Diex Research
Click to view our video !Hope on the horizon for Alzheimer’s disease
There is good news for people suffering from Alzheimer’s disease and their close relatives. American health authority FDA has just accepted the application from medication Aducanumab2 to request authorization for the American market. When started at an early stage, this medication would become the first immunotherapy with the potential to slow down neurodegeneration associated with Alzheimer’s disease.
read more2020 is off to a consistent start at DIEX Recherche Victoriaville
Sherbrooke, March 11, 2020 – DIEX Recherche Victoriaville has been selected as one of three finalists for the Company section in the Retail and Service Business category for the 37th edition of the Panthéon de la Performance. All 11 finalists were announced on March 10 at the Cabaret Guy Aubert in Carre 150. Learn More